查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1782021

微创活检技术市场，按产品提供、按技术、按循环生物标记、按应用、按最终用户、按国家和地区划分 - 2025 年至 2032 年全球行业分析、市场规模、市场份额及预测

Minimally Invasive Biopsy Techniques Market, By Product Offered, By Technique, By Circulating Biomarker, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 393 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年微创切片技术市场规模价值为 131.4612 亿美元，2025 年至 2032 年的复合年增长率为 10.5%。

微创切片技术市场-市场动态

全球癌症盛行率的不断上升以及精准诊断日益增长的重要性预计将推动市场成长。

随着全球癌症发生率持续上升，迫切需要早期、精准且微创的诊断方法。与传统手术方法相比，包括细针穿刺、芯针活检和液体活检在内的微创活检技术可缩短患者恢復时间，减轻患者不适，并降低併发症发生率。世界卫生组织估计，到2050年，新增癌症病例预计将达到3,500万例，比2022年记录的2,000万例增加77%。儘管如此，对肿瘤学研究、个人化医疗和医疗创新的投入不断增加，或将为市场扩张带来机会。此外，先进活检系统的高昂成本可能会阻碍市场成长。

微创活检技术市场—关键见解

根据我们的研究分析师的分析，预计全球市场在预测期内（2025-2032 年）的年复合成长率约为 10.5%。

根据产品供应细分，预计套件和耗材将在 2024 年占据最大市场份额

根据技术细分，液体活检是 2024 年的领先技术

根据循环生物标记细分，游离 DNA（cfDNA）是 2024 年领先的循环生物标记

根据应用细分，临床是 2024 年领先的应用

根据最终用户细分，医院和诊所是 2024 年的主要最终用户

从地区来看，北美是 2024 年最大的收入来源

微创活检技术市场細項分析：

全球微创活检技术市场根据产品供应、技术、循环生物标记、应用、最终用户和地区进行细分。

根据产品类型，市场可分为三个部分：检测试剂、试剂盒及耗材以及仪器。试剂盒及耗材因其使用频率高、一次性使用以及在确保诊断程序无菌和准确方面发挥重要作用，在市场中占据主导地位。此类产品包括活检针、镊子、注射器、试剂和样本采集容器，所有这些对于各种活检方法都至关重要，包括细针抽吸、芯针活检和真空辅助活检。医院、诊断实验室和门诊对这些产品的持续需求显着提升了其庞大的市场份额。

根据技术，市场可分为四大细分领域：液体切片、光学切片、刷检、色素病变检测及其他。液体活检正处于市场扩张的前沿，因为它能够透过简单的抽血来识别癌症相关的生物标誌物，从而提供比传统组织活检更安全、更快捷、更以患者为中心的替代方案。它有助于即时监测病情进展、早期癌症检测和评估治疗效果，且无需侵入性操作。精准医疗的日益普及以及对早期癌症诊断需求的不断增长，推动了液体活检在各种临床环境中的快速发展和普及。

根据循环生物标记物，市场可分为四个细分领域：循环肿瘤细胞 (CTC)、游离DNA (cfDNA)、循环肿瘤DNA (ctDNA)、细胞外囊泡及其他。游离DNA (cfDNA) 是市场成长的主要驱动力。在液体活检领域，游离DNA (cfDNA) 因其在非侵入性癌症诊断和监测中的重要作用而处于市场扩张的前沿。透过分析肿瘤释放到血液中的DNA片段，cfDNA有助于识别基因突变、肿瘤负荷和治疗抗药性。它无需手术干预即可即时洞察肿瘤动态，已成为精准肿瘤学的基础要素。

根据应用，市场可分为两类：临床和治疗。临床是市场成长的主要驱动力。临床应用是微创活检技术市场扩张的前沿，这得益于这些技术在标准诊断和疾病监测中的日益普及。医院、诊断实验室和专科诊所正在逐步采用液体活检、细针穿刺和影像引导活检等微创技术，以实现早期发现和个人化治疗计划，尤其是在肿瘤学领域。

根据最终用户，市场可分为三类：医院和诊所、学术和研究机构以及门诊护理中心。医院和诊所凭藉其庞大的患者数量、先进的诊断设施以及专业医护人员的专业知识，在微创活检技术领域的最终用户中占据市场成长的前沿。这些场所是疾病检测的主要场所，尤其是在肿瘤科，通常进行细针抽吸、芯针活检和液体活检等操作。学术和研究机构也发挥着至关重要的作用，致力于创新活检方法的进步和生物标誌物的发现。相较之下，由于人们越来越倾向于门诊、经济高效且恢復时间更快的微创手术，门诊护理中心的采用率正在上升。

微创活检技术市场-地理洞察

北美引领市场成长，主要得益于液体活检的日益普及。癌症发生率的上升，以及对早期诊断和精准诊断的高度重视，加速了液体活检在临床实践中的应用。此外，知名生物技术公司、先进的医疗基础设施以及支援性监管框架的存在，进一步推动了市场成长。美国人口超过3.3亿，拥有全球最复杂的医疗保健体系之一，其特点是医疗服务提供者、付款人和接受治疗的患者之间相互关联。由于成像和导航技术的进步，欧洲成为市场成长第二大地区。

微创切片技术市场-竞争格局：

微创活检技术市场的竞争环境以众多知名医疗器材製造商、诊断公司和新兴生物技术新创公司的参与为特征。领先的公司正在开发先进的影像引导、机器人辅助和人工智慧整合的活检解决方案，旨在提高准确性并降低手术风险。各机构正在投资非侵入性液体活检技术，尤其是那些专注于循环肿瘤DNA (ctDNA) 和游离DNA (cfDNA) 的技术，以实现即时癌症监测。此外，各公司正在拓展其在亚太和拉丁美洲地区的业务，以利用对微创诊断方法日益增长的需求。

最新动态：

2025年1月22日，位于厄本代尔和克莱夫的爱荷华州GRACE乳房影像与医疗水疗中心（GRACE Breast Imaging & Medical Spa）取得了重大里程碑，成为美国首家安装创新Mammomat B.brilliant的医疗机构。这标誌着西门子医疗十多年来首次对乳房X光检查平台进行全面重新设计。 Mammomat B.brilliant融合了先进的3D影像撷取和影像重建技术，并具备全视野数位乳房X光检查功能，包括二维乳房成像、乳房活检和钛增强乳房X光检查。

目录

第一章：微创活检技术市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 微创活检技术市场片段（按产品提供）
    • 微创活检技术市场片段（按技术）
    • 循环生物製造商的微创活检技术市场摘要
    • 微创活检技术市场片段（按应用）
    • 微创活检技术市场片段（按最终用户）
    • 各国微创切片技术市场概况
    • 微创活检技术市场（按地区）
  • 竞争洞察

第三章：微创切片技术关键市场趋势

  • 微创活检技术市场驱动因素
    • 市场驱动因素的影响分析
  • 微创切片技术市场限制
    • 市场限制的影响分析
  • 微创切片技术市场机会
  • 微创活检技术市场未来趋势

第四章：微创切片技术产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：微创切片技术市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：微创切片技术市场格局

  • 2024年微创切片技术市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：微创切片技术市场－依产品分类

  • 概述
    • 按产品细分市场占有率分析
    • 测试
    • 套件和耗材
    • 仪器

第 8 章：微创活检技术市场 - 按技术

  • 概述
    • 按技术分类的细分市场占有率分析
    • 液体活检
    • 光学活检
    • 刷检
    • 色素病灶检测
    • 其他的

第九章：微创切片技术市场－循环生物製造商

  • 概述
    • 按循环生物製造商分類的细分市场份额分析
    • 循环肿瘤细胞（CTC）
    • 游离DNA（cfDNA）
    • 循环肿瘤DNA（ctDNA）
    • 细胞外囊泡
    • 其他的

第 10 章：微创活检技术市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 临床
      • 治疗监测
      • 预后和復发监测
      • 治疗选择
      • 其他的
    • 治疗
      • 肺癌
      • 乳癌
      • 摄护腺癌
      • 大肠直肠癌
      • 其他的

第 11 章：微创活检技术市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院和诊所
    • 学术及研究机构
    • 门诊护理中心

第 12 章：微创活检技术市场 - 按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美微创活检技术主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品提供）
    • 北美市场规模和预测（按技术）
    • 北美市场规模及预测（按循环生物製造商）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲微创活检技术主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（按产品提供）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模及预测（按循环生物製造商）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区微创切片技术主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品提供）
    • 亚太地区市场规模及预测（依技术）
    • 亚太地区市场规模及预测（按循环生物製造商）
    • 亚太地区市场规模及预测（按应用）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲微创活检技术主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品提供）
    • 拉丁美洲市场规模及预测（按技术）
    • 拉丁美洲市场规模及预测（按循环生物製造商）
    • 拉丁美洲市场规模及预测（按应用）
    • LATAM 规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲微创活检技术主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按产品提供）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按循环生物製造商）
    • 中东和非洲市场规模和预测（按应用）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 13 章：关键供应商分析-微创活检技术产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Becton, Dickinson and Company (BD)
    • Danaher Corporation (Leica Biosystems)
    • Hologic, Inc.
    • Boston Scientific Corporation
    • Medtronic plc
    • Siemens Healthineers
    • GE HealthCare
    • Philips Healthcare
    • Argon Medical Devices
    • Cook Medical
    • Fujifilm Holdings Corporation
    • Olympus Corporation
    • R. Bard (now part of BD)
    • Biocept, Inc.
    • Guardant Health
    • Qiagen NV
    • Exact Sciences Corporation
    • Bio-Rad Laboratories
    • Menarini Silicon Biosystems
    • NeoGenomics Laboratories
    • Others

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5422

REPORT HIGHLIGHT

Minimally Invasive Biopsy Techniques Market size was valued at US$ 13,146.12 Million in 2024, expanding at a CAGR of 10.5% from 2025 to 2032.

Minimally invasive biopsy techniques refer to procedures that obtain tissue samples for diagnostic purposes through smaller incisions and with less damage to surrounding tissue than traditional surgical biopsies. These methods present benefits such as diminished scarring, quicker recovery times, and a lower likelihood of complications. Frequently utilized techniques include fine-needle aspiration (FNA), core needle biopsy (CNB), and vacuum-assisted biopsy (VAB), which are often performed with the assistance of imaging technologies such as ultrasound, MRI, or mammography. Overall, minimally invasive biopsy techniques represent a significant advancement in tissue sampling, delivering precise diagnoses while minimizing the burden on patients.

Minimally Invasive Biopsy Techniques Market- Market Dynamics

The increasing global prevalence of cancer, along with the growing significance of precision diagnostics, is anticipated to propel market growth.

As the incidence of cancer continues to rise globally, there is an urgent requirement for early, precise, and less invasive diagnostic methods. Minimally invasive biopsy techniques, including fine-needle aspiration, core needle biopsy, and liquid biopsy, provide quicker recovery times, decreased patient discomfort, and lower rates of complications when compared to conventional surgical approaches. The World Health Organization estimates that the number of new cancer cases is expected to reach 35 million by 2050, which signifies a 77% increase from the 20 million cases documented in 2022. Nevertheless, increasing investments in oncology research, personalized medicine, and healthcare innovation may present opportunities for market expansion. Furthermore, the high costs associated with advanced biopsy systems could hinder market growth.

Minimally Invasive Biopsy Techniques Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.5% over the forecast period (2025-2032)

Based on Product Offered segmentation, Kits & Consumables were predicted to show the maximum market share in the year 2024

Based on Technique segmentation, Liquid Biopsy was the leading Technique in 2024

Based on Circulating Biomarker segmentation, cell-free DNA (cfDNA) was the leading Circulating Biomarker in 2024

Based on Application segmentation, Clinical was the leading Application in 2024

Based on end-user segmentation, Hospitals and clinics were the leading end users in 2024

Based on region, North America was the leading revenue generator in 2024

Minimally Invasive Biopsy Techniques Market- Segmentation Analysis:

The Global Minimally Invasive Biopsy Techniques Market is segmented based on Product Offered, Technique, Circulating Biomarker, Application, End User, and Region.

The market is divided into three segments according to the Products Offered: Tests, Kits & Consumables, and Instruments. Kits & Consumables occupy a leading role in the market, attributed to their frequent usage, disposability, and essential function in ensuring sterile and accurate diagnostic procedures. This category encompasses biopsy needles, forceps, syringes, reagents, and sample collection containers, all of which are vital for various biopsy methods, including fine-needle aspiration, core needle biopsy, and vacuum-assisted biopsy. The ongoing demand for these products in hospitals, diagnostic laboratories, and outpatient settings significantly boosts their substantial market share.

The market is categorized into four segments based on Technique: Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, and Others. Liquid Biopsy is at the forefront of market expansion, owing to its capability to identify cancer-related biomarkers through a straightforward blood draw, providing a safer, quicker, and more patient-centric alternative to conventional tissue biopsies. It facilitates real-time monitoring of disease progression, early cancer detection, and evaluation of treatment responses without requiring invasive procedures. The growing adoption of precision medicine and the increasing demand for early cancer diagnostics are propelling the swift growth and acceptance of liquid biopsy in various clinical environments.

The market is categorized into four segments based on circulating Biomarkers: Circulating Tumor Cells (CTCs), Cell-Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, and Others. Cell-Free DNA (cfDNA) is the primary driver of market growth. Within the liquid biopsy sector, cell-free DNA (cfDNA) is at the forefront of market expansion due to its essential function in non-invasive cancer diagnostics and monitoring. By analyzing fragments of DNA released by tumors into the bloodstream, cfDNA facilitates the identification of genetic mutations, tumor burden, and treatment resistance. Its capacity to deliver real-time insights into tumor dynamics without requiring surgical interventions has established it as a fundamental element in precision oncology.

The market is segmented into two categories according to Application: Clinical and Therapeutic. Clinical is the primary driver of market growth. Clinical applications are at the forefront of market expansion in minimally invasive biopsy techniques, propelled by the rising adoption of these procedures in standard diagnostics and disease monitoring. Hospitals, diagnostic laboratories, and specialty clinics are progressively employing minimally invasive techniques such as liquid biopsy, fine-needle aspiration, and image-guided biopsies for early detection and tailored treatment planning, especially in the field of oncology.

The market is segmented into three categories based on End-User: Hospitals & Clinics, Academic & Research Institutions, and Ambulatory Care Centers. Hospitals and clinics are at the forefront of market growth among end users in the minimally invasive biopsy techniques sector, attributed to the high patient volume, the presence of advanced diagnostic facilities, and the expertise of medical professionals. These environments serve as the primary point of care for disease detection, particularly in oncology, where procedures such as fine-needle aspiration, core needle biopsy, and liquid biopsy are commonly conducted. Academic and research institutions also play a vital role, concentrating on the advancement of innovative biopsy methods and the discovery of biomarkers. In contrast, ambulatory care centers are witnessing an increase in adoption due to the growing preference for outpatient, cost-effective, and minimally invasive procedures that offer faster recovery times.

Minimally Invasive Biopsy Techniques Market- Geographical Insights

North America leads in market growth, primarily due to the increasing adoption of liquid biopsy. The rising incidence of cancer, along with a strong focus on early and accurate diagnosis, has expedited the incorporation of liquid biopsy into clinical practices. Furthermore, the presence of prominent biotechnology firms, sophisticated healthcare infrastructure, and supportive regulatory frameworks has further propelled market growth. The United States (US), with a population exceeding 330 million, benefits from one of the most intricate healthcare systems globally, characterized by the interconnected relationships among providers, payers, and patients receiving care. Europe ranks as the second largest region for market growth, attributed to advancements in imaging and navigation technologies.

Minimally Invasive Biopsy Techniques Market- Competitive Landscape:

The competitive environment of the Minimally Invasive Biopsy Techniques Market is characterized by the participation of various established medical device manufacturers, diagnostic firms, and emerging biotech startups. Leading companies are developing advanced imaging-guided, robotic-assisted, and AI-integrated biopsy solutions designed to enhance accuracy and reduce procedural risks. Organizations are investing in non-invasive liquid biopsy technologies, especially those focusing on circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA), to enable real-time cancer monitoring. Furthermore, companies are broadening their operations in the Asia-Pacific and Latin America regions to take advantage of the growing demand for less invasive diagnostic approaches.

Recent Developments:

On January 22, 2025, GRACE Breast Imaging & Medical Spa of Iowa, located in Urbandale and Clive, achieved a significant milestone by becoming the first healthcare facility in the United States to install the innovative Mammomat B.brilliant. This marks the first complete redesign of a mammography platform by Siemens Healthineers in over ten years. The Mammomat B.brilliant incorporates advanced 3D image acquisition and image reconstruction technology, along with capabilities for full-field digital mammography, which includes two-dimensional breast imaging, breast biopsy, and titanium contrast-enhanced mammography.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Becton, Dickinson and Company (BD)
  • Danaher Corporation (Leica Biosystems)
  • Hologic, Inc.
  • Boston Scientific Corporation
  • Medtronic plc
  • Siemens Healthineers
  • GE HealthCare
  • Philips Healthcare
  • Argon Medical Devices
  • Cook Medical
  • Fujifilm Holdings Corporation
  • Olympus Corporation
  • R. Bard (now part of BD)
  • Biocept, Inc.
  • Guardant Health
  • Qiagen N.V.
  • Exact Sciences Corporation
  • Bio-Rad Laboratories
  • Menarini Silicon Biosystems
  • NeoGenomics Laboratories
  • Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY PRODUCT OFFERED- MARKET ANALYSIS, 2019 - 2032

  • Tests
  • Kits & Consumables
  • Instruments

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032

  • Liquid Biopsy
  • Optical Biopsy
  • Brush Biopsy
  • Pigmented Lesion Assays
  • Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY CIRCULATING BIOMAKER- MARKET ANALYSIS, 2019 - 2032

  • Circulating Tumor Cells (CTCs)
  • Cell Free DNA (cfDNA)
  • Circulating Tumor DNA (ctDNA)
  • Extracellular Vesicles
  • Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Clinical
  • Treatment Monitoring
  • Prognosis & Recurrence Monitoring
  • Treatment Selection
  • Others
  • Therapeutic
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Academic & Research Institutions
  • Ambulatory Care Centers

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Minimally Invasive Biopsy Techniques Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Minimally Invasive Biopsy Techniques Market Snippet by Product Offered
    • 2.1.2. Minimally Invasive Biopsy Techniques Market Snippet by Technique
    • 2.1.3. Minimally Invasive Biopsy Techniques Market Snippet by Circulating Biomaker
    • 2.1.4. Minimally Invasive Biopsy Techniques Market Snippet by Application
    • 2.1.5. Minimally Invasive Biopsy Techniques Market Snippet by End User
    • 2.1.6. Minimally Invasive Biopsy Techniques Market Snippet by Country
    • 2.1.7. Minimally Invasive Biopsy Techniques Market Snippet by Region
  • 2.2. Competitive Insights

3. Minimally Invasive Biopsy Techniques Key Market Trends

  • 3.1. Minimally Invasive Biopsy Techniques Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Minimally Invasive Biopsy Techniques Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Minimally Invasive Biopsy Techniques Market Opportunities
  • 3.4. Minimally Invasive Biopsy Techniques Market Future Trends

4. Minimally Invasive Biopsy Techniques Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Minimally Invasive Biopsy Techniques Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Minimally Invasive Biopsy Techniques Market Landscape

  • 6.1. Minimally Invasive Biopsy Techniques Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Minimally Invasive Biopsy Techniques Market - By Product Offered

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Offered, 2024 & 2032 (%)
    • 7.1.2. Tests
    • 7.1.3. Kits & Consumables
    • 7.1.4. Instruments

8. Minimally Invasive Biopsy Techniques Market - By Technique

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technique, 2024 & 2032 (%)
    • 8.1.2. Liquid Biopsy
    • 8.1.3. Optical Biopsy
    • 8.1.4. Brush Biopsy
    • 8.1.5. Pigmented Lesion Assays
    • 8.1.6. Others

9. Minimally Invasive Biopsy Techniques Market - By Circulating Biomaker

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Circulating Biomaker, 2024 & 2032 (%)
    • 9.1.2. Circulating Tumor Cells (CTCs)
    • 9.1.3. Cell Free DNA (cfDNA)
    • 9.1.4. Circulating Tumor DNA (ctDNA)
    • 9.1.5. Extracellular Vesicles
    • 9.1.6. Others

10. Minimally Invasive Biopsy Techniques Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Clinical
      • 10.1.2.1. Treatment Monitoring
      • 10.1.2.2. Prognosis & Recurrence Monitoring
      • 10.1.2.3. Treatment Selection
      • 10.1.2.4. Others
    • 10.1.3. Therapeutic
      • 10.1.3.1. Lung Cancer
      • 10.1.3.2. Breast Cancer
      • 10.1.3.3. Prostate Cancer
      • 10.1.3.4. Colorectal Cancer
      • 10.1.3.5. Others

11. Minimally Invasive Biopsy Techniques Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Hospitals & Clinics
    • 11.1.3. Academic & Research Institutions
    • 11.1.4. Ambulatory Care Centers

12. Minimally Invasive Biopsy Techniques Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Minimally Invasive Biopsy Techniques Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Minimally Invasive Biopsy Techniques Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Becton, Dickinson and Company (BD)
    • 13.2.2. Danaher Corporation (Leica Biosystems)
    • 13.2.3. Hologic, Inc.
    • 13.2.4. Boston Scientific Corporation
    • 13.2.5. Medtronic plc
    • 13.2.6. Siemens Healthineers
    • 13.2.7. GE HealthCare
    • 13.2.8. Philips Healthcare
    • 13.2.9. Argon Medical Devices
    • 13.2.10. Cook Medical
    • 13.2.11. Fujifilm Holdings Corporation
    • 13.2.12. Olympus Corporation
    • 13.2.13. R. Bard (now part of BD)
    • 13.2.14. Biocept, Inc.
    • 13.2.15. Guardant Health
    • 13.2.16. Qiagen N.V.
    • 13.2.17. Exact Sciences Corporation
    • 13.2.18. Bio-Rad Laboratories
    • 13.2.19. Menarini Silicon Biosystems
    • 13.2.20. NeoGenomics Laboratories
    • 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us